Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

RSS icon

Meta-analysis: Intensive lipid lowering only beneficial at higher LDL levels

Intensive lipid-lowering therapy significantly reduces all-cause and cardiovascular mortality—but only for patients with low-density lipoprotein cholesterol (LDL-C) levels above 100 mg/dL, according to a meta-analysis published April 17 in JAMA.

The 5 behaviors that could cut CVD-related mortality by 82%

Living a healthy lifestyle during adulthood could prolong life expectancy at age 50 by 14 years for women and more than 12 years for men, according to new research published April 30 in the American Heart Association’s Circulation journal.

Thumbnail

AHA: Nutrition education for med students often overlooked

A healthy diet is a cornerstone to preventing cardiovascular disease, but many healthcare providers receive insufficient nutrition education and training, according to a new scientific advisory released by the American Heart Association.

Real-World Study Shows INVOKANA® (canagliflozin) 300mg Demonstrates Better Blood Glucose Control Than Farxiga® (dapagliflozin) 10mg in Patients with Type 2 Diabetes

TITUSVILLE, N.J., April 27, 2018 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the results of a real-world study showing that adults with type 2 diabetes initiated on INVOKANA® (canagliflozin) 300mg had significantly better blood glucose control, based on A1C goal attainment and reduction, compared to similar patients initiated on Farxiga®(dapagliflozin) 10mg.

Thumbnail

Prediabetes, hypertension combo increases risk of cardiovascular disease

A combination of prediabetes and hypertension increases the risk for cardiovascular disease (CVD) more than either risk factor alone, according to new research published April 18 in Hypertension.

Thumbnail

Patients with 'white-coat syndrome' 79% more likely to die of hypertension

Ambulatory blood pressure measurements are a stronger predictor of all-cause and cardiovascular mortality than clinical blood pressure measurements, according to a study published April 19 in the New England Journal of Medicine.

Thumbnail

6% of children have new or worsening hypertension under updated guidelines

Although they didn’t garner as much attention as the adult guidelines, the criteria for determining hypertension in children also changed in 2017. They led to an increase in individuals considered outside the normal range, according to a study published online April 23 in JAMA Pediatrics.

Thumbnail

Mindfulness may positively impact cardiovascular health

New research from Michigan Technological University suggests an hour of mindfulness meditation can reduce anxiety and positively impact cardiovascular health—in particular, blood pressure. Study findings were presented April 23 at the 2018 Experimental Biology Meeting in San Diego.

Displaying 921 - 928 of 1158

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.